Healthy Volunteer and Patient Studies
The most critical to the success of an early phase clinical trial is the recruitment and retention of the right participants. Be it healthy volunteers, or patients, the Accelsiors Phase I unit is positioned to respond to all your needs. With the unique specialized database of healthy volunteers and patients, in addition to being positioned right in the middle of a tertiary-level healthcare institution, our integration with the hospital grounds gives us the ability to accelerate and expand clinical research into Phase IIa and beyond.
Key Features of Our Healthy Volunteer and Patient Studies
Accelsiors Phase I unit has robust databases of healthy volunteers tailored to meet a wide array of trial requirements. Utilising our advanced databases, strategic partnerships, and experienced recruitment team, we can quickly identify and enroll participants with complex profiles. This includes participants with specific comorbidities, rare conditions, or demographic requirements, ensuring your study meets enrollment targets efficiently. For example, beyond standard age ranges (18–55), we offer access to:
- Elderly healthy volunteers.
- Postmenopausal women.
- Patients with mild cognitive impairment.
- Patients with Type 2 diabetes.
- Obese individuals.
- Patients with mild renal impairment.
- Patients with mild liver impairment.
These specialised populations ensure that your trial can recruit participants precisely aligned with your study objectives, enabling faster and more targeted data collection.
Being in the very epicenter of hospital grounds, in the heart of a tertiary-level healthcare-providing university hospital, the Accelsiors Phase I unit has unparalleled advantages. Our Phase I unit can collaborate directly with specialised departments for trials requiring niche expertise or advanced patient populations. As Accelsiors Phase I unit maintains strong connections with Site Management Organisations (SMOs) and specialised healthcare facilities, that us to extend and accelerate clinical programs with ease. These partnerships ensure that the same high standards of care and data quality are upheld as trials progress into later phases or require more geographically diverse recruitment. This seamless integration supports the smooth transition of research into Phase IIa portions of the development programme, ensuring continuous quality and exceptional work throughout the clinical journey.
Our Phase I unit is designed to go beyond traditional first-in-human studies, with the infrastructure, expertise, and connectivity to expand into comprehensive early-phase programs. By integrating Phase IIa capabilities, we provide a unified approach that reduces timelines, minimises operational handoffs, and accelerates the overall development process. Our ability to maintain trial continuity, from Phase I through Phase IIa and beyond, is a hallmark of our service. This is achieved through:
- Consistent data standards and quality across all phases.
- Collaboration with specialized departments and institutions for therapeutic expertise.
- Long-term planning and alignment with sponsors’ development goals.
- Tailored Databases: Access to diverse populations, including specialized and comorbid groups.
- Strategic Location: Direct collaboration with tertiary-level hospital departments for complex trials.
- End-to-End Integration: From Phase I to Phase IIa, ensuring seamless progression and continuity.
- Strong Network: Partnerships with SMOs and healthcare institutions to scale and accelerate your research.
- Efficient Recruitment: Rapid access to qualified participants for faster trial initiation and execution.
Our Phase I unit is purpose-built to maximize efficiency, minimize delays, and provide high-quality data that will confidently and quickly advance your early-phase clinical research.
